Video

Dr. O'Malley on Racial and Economic Barriers to Screening in CRC

Denalee O'Malley, PhD, discusses racial and economic barriers to colorectal screening in colorectal cancer.

Denalee O'Malley, PhD, assistant professor, Department of Family Medicine and Community Health, Research Division, Rutgers Robert Wood Johnson Medical School, discusses racial and economic barriers to colorectal screening in colorectal cancer (CRC).

The disparities that affect screening for CRC stem from structural racism embedded in the health-care delivery system, O'Malley says. These disparities are interconnected, and they include racism, income inequality, geographic disparities, and the organization and delivery of health care, O'Malley explains.

Moreover, there are many different types of CRC screening tests, all with different levels of efficacy and intervals of testing, O’Malley adds. A FIT test is an annual screening, compared with a colonoscopy, which involves a 10-year interval if tests come back normal, O’Malley continues.

Community health centers play a key part in screenings, as they are considered a primary care safety net, O’Malley explains. However, over 20% of community health center patient populations are uninsured, adding another disparity to screening, O’Malley concludes.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD